# Assessing Imaging as a Tool in Monitoring and Predicting the Progression of Parkinson Disease

> **NCT00404170** · PHASE2 · COMPLETED · sponsor: **Institute for Neurodegenerative Disorders** · enrollment: 396 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** B-CIT and SPECT imaging

## Key facts

- **NCT ID:** NCT00404170
- **Lead sponsor:** Institute for Neurodegenerative Disorders
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 396 (ACTUAL)
- **Last updated:** 2022-07-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00404170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00404170, "Assessing Imaging as a Tool in Monitoring and Predicting the Progression of Parkinson Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00404170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*